From: The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population
Characteristics | Total (204) | Metastatic (27) | Non-metastatic (177) | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | P | |
Age | |||||||
 Mean (SD) | 57.50 | 4.0 | 57.56 | 4.56 | 57.48 | 4.15 | 0.91 |
 Median (SD) | 58.0 | 7.0 | 57.0 | 8.0 | 58.0 | 7.0 |  |
 50–54 | 56 | 27.0 | 7 | 26.0 | 49 | 28.0 |  |
 55–60 | 92 | 45.0 | 12 | 44.0 | 80 | 45.0 |  |
  ≥ 61 | 56 | 28.0 | 8 | 30.0 | 48 | 27.0 |  |
Gender | |||||||
 Male | 112 | 54.90 | 17 | 63.0 | 95 | 53.67 | 0.37 |
 Female | 92 | 45.10 | 10 | 37.0 | 82 | 46.33 | |
Member location | |||||||
 Rural | 110 | 53.92 | 11 | 41.0 | 99 | 56.0 | 0.14 |
 Urban | 94 | 46.08 | 16 | 59.0 | 78 | 44.0 | |
Travel time (min) | |||||||
 Mean (SD) | 33.58 | 40.0 | 34.85 | 51.53 | 33.38 | 38.12 | 0.74 |
 Median (SD) | 19.0 | 27.0 | 18.0 | 17.0 | 19.0 | 28.0 | |
 Q1 | 11 | – | 13 | – | 11 | – |  |
 Q2 | 19 | – | 18 | – | 19 | – |  |
 Q3 | 38 | – | 30 | – | 39 | – |  |
 Q4 | 227 | – | 223 | – | 227 | – |  |
Travel distance, (miles) | |||||||
 Mean (SD) | 29.0 | 43.0 | 30.0 | 58.0 | 29.0 | 40.50 | 0.74 |
 Median (SD) | 13.0 | 26.0 | 13.0 | 19.0 | 13.0 | 28.50 | |
 Q1 | 5.0 | – | 5.0 | – | 4.50 | – |  |
 Q2 | 13.0 | – | 13.0 | – | 13.0 | – |  |
 Q3 | 31.0 | – | 24.0 | – | 33.0 | – |  |
 Q4 | 251.0 | – | 251.0 | – | 234.0 | – |  |
PCP access | |||||||
 PCP/10,000 mean | 11.03 | 8.10 | 12.33 | 12.08 | 10.82 | 7.31 | 0.95 |
 PCP/10,000 median | 10.08 | 8.51 | 7.82 | 13.58 | 10.24 | 8.19 | |
Year of CRC diagnosis | |||||||
 2012 | 33 | 16.0 | 7 | 26.0 | 26 | 15.0 |  |
 2013 | 50 | 25.0 | 4 | 15.0 | 46 | 26.0 |  |
 2014 | 62 | 30.0 | 11 | 41.0 | 51 | 29.0 |  |
 2015 | 39 | 19.0 | 5 | 18.0 | 34 | 19.0 |  |
 2016 | 20 | 10.0 | 0 | 0 | 20 | 11.0 |  |
Months of enrollment before CRC diagnosis | |||||||
 Mean (SD) | 26 | 13.50 | 25 | 13.0 | 26 | 13.53 |  |
 Median (IQR) | 26 | 22.0 | 28 | 26.0 | 25 | 22.0 |  |